Submit an abstract for the Spotlight on Immuno-Oncology conference by June 2, 11:59 p.m. PT
ASGCT Members have access to all of our Professional Development Cafes. Become a member today and watch all the cafes on demand!
Join Now
During this café, ASGCT Member Stephen Gottschalk, MD (St. Jude's Children's Research Hospital) led a structured discussion about CAR T-cell therapy.
This café is the first of a two-part series hosted by Andrew Steinsapir, a gene therapy program lead at Deerfield Discovery and Development.
Following a successful part one, April’s Professional Development Café brought attendees to the second part of this two-part series once again hosted by Andrew Steinsapir.
ASGCT Associate Member Vincenzo Cerullo, PhD, discussed tumor-infiltrating lymphocytes (TILs) and tumor-specific antigens (TSAs).
Attendees heard from speakers Gautam Ranade, Jasna Curak, and Stephan Croft during this session on Good Manufacturing Practices (GMPs).
Are you interested in starting your own gene or cell therapy company? Learn more about the process from Matthew Hirsch, PhD, R. Jude Samulski, PhD, and Ben Yerxa, PhD.
Grant Holley, PhD, talked to attendees about how to better exxplain what they do in the lab and why they do it.
We heard from Curtis Henry, PhD, who shared his insights on how to build and maintain an effective team.
Speakers Ben Hurlbut, PhD, and Krishanu Saha, PhD, explored the ethical dimensions of research undertaken by the ASGCT community.
During this session, attendees will learn how to create an "elevator pitch" for their theses.
Sept. 18-19 | Washington, DC
© 2000-2023 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico